Vascular invasion and stromal S100A4 expression at the invasive front of colorectal cancer are novel determinants and tumor prognostic markers

Journal of Cancer

Volumn 8, Issue 9, 2017, Pages 1552-1561

  Sugai, Tamotsu ^a   Yamada, Noriyuki ^a   Eizuka, Makoto ^a   Sugimoto, Ryo ^a   Uesugi, Noriyuki ^a   Osakabe, Mitsumasa ^a   Ishida, Kazuyuki ^a   Otsuka, Kouki ^a   Sasaki, Akira ^a   Matsumoto, Takayuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Prognostic marker; S100A4; Tumor budding; Vascular invasion

Indexed keywords

CALVASCULIN; EOSIN; FLUOROURACIL; FOLINIC ACID; HEMATOXYLIN; KALININ; KALININ GAMMA2; MATRILYSIN; TUMOR MARKER; UFT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTIVE VALUE; PROTEIN EXPRESSION; STROMA CELL; SURVIVAL ANALYSIS; TISSUE MICROARRAY; TUMOR INVASION; TUMOR LOCALIZATION; VASCULAR INVASION;

EID: 85021197073     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.18685     Document Type: Article

References (34)

1. Mehrkhani F, Nasiri S, Donboli K, et al. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis. 2009;11:157-61.
2. von Winterfeld M, Hoffmeister M, Ingold-Heppner B, et al. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition. Eur J Cancer. 2014;50:2958-65.
3. Jiang PC, Zhu L, Fan Y, et al. Clinicopathological and biological significance of cripto overexpression in human colon cancer. World J Gastroenterol. 2013;19 (46):8630-7.
4. Akishima-Fukasawa Y, Ishikawa Y, Akasaka Y, et al. Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer. Histopathology. 2011;59:470-81.
5. Courtney ED, West NJ, Kaur C, et al. Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer. Colorectal Dis. 2009;11:150-6.
6. McClelland D, Murray GI. A Comprehensive Study of Extramural Venous Invasion in Colorectal Cancer. PLoS One. 2015;10:e0144987.
7. Polistena A, Cucina A, Dinicola S, et al. MMP7 expression in colorectal tumours of different stages. In Vivo. 2014;28:105-10.
8. Karamitopoulou E, Zlobec I, Panayiotides I, et al. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol. 2011;42:1888-96.
9. Masaki T, Matsuoka H, Sugiyama M, et al. Laminin-5 gamma2 chain expression as a possible determinant of tumor aggressiveness in T1 colorectal carcinomas. Dig Dis Sci. 2003;48:272-8.
10. Weidle UH, Birzele F, Krüger A. Molecular targets and pathways involved in liver metastasis of colorectal cancer. Clin Exp Metastasis. 2015;32:623-35.
11. Niu Y, Wang L, Cheng C, et al. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma. APMIS. 2015;123:93-101.
12. Sun DW, Zhang YY, Qi Y, et al. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis. Cancer Epidemiol. 2015;39:135-42.
13. Aoki S, Nakanishi Y, Akimoto S, et al. Prognostic significance of laminin-5 gamma2 chain expression in colorectal carcinoma: immunohistochemical analysis of 103 cases. Dis Colon Rectum. 2002;45:1520-7.
14. Puppa G, Senore C, Sheahan K, et al. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology. 2012;61:562-75.
15. Ueno H, Shinto E, Kajiwara Y, et al. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer. Br J Cancer. 2014;111 :2082-90.
16. Galván JA, Helbling M, Koelzer VH, et al. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer. Oncotarget. 2015;6:874-85.
17. Tommelein J, Verset L, Boterberg T, et al. Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer. Front Oncol. 2015;5:63.
18. Ueno H, Murphy J, Jass JR, et al. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127-32.
19. Shinto E, Mochizuki H, Ueno H, et al. A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci. Histopathology. 2005;47:25-31.
20. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal Carcinoma, Second English Edition. Kanehara Co.: Tokyo. 2009: 30-63.
21. Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2010;1:651-61.
22. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178-96.
23. Sugai T, Habano W, Jiao Y-F, et al. Analysis of molecular alterations in leftand right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 2006; 8: 193-201.
24. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337.
25. Snover D, Ahnen DJ, Burt R et al. Serrated polyps of the colon and rectum and serrated ("hyperplastic") polyposis. In: Bosman FT, Carneiro F, Hruban RH, et al, (eds) WHO Classification of Tumours Pathology and genetics Tumours of the digestive system, 4th edn. Berlin: Springer-Verlag, 2010.
26. Kojima M, Shimazaki H, Iwaya K, et al. Pathological diagnostic criterion of blood and lymphatic vessel invasion in colorectal cancer: a framework for developing an objective pathological diagnostic system using the Delphi method, from the Pathology Working Group of the Japanese Society for Cancer of the Colon and Rectum. J Clin Pathol. 2013;66:551-8.
27. Fanjul-Fernández M, Folgueras AR, Cabrera S, et al. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta. 2010;1803:3-19.
28. Lenander C, Roblick UJ, Habermann JK, et al. Laminin 5 gamma 2 chain expression: a marker of early invasiveness in colorectal adenomas. Mol Pathol. 2003;56:342-6.
29. Kwak JM, Lee HJ, Kim SH, et al. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer. World J Gastroenterol. 2010;16:3897-904.
30. Sack U, Walther W, Scudiero D, et al. S100A4-induced cell motility and metastasis is restricted by the Wnt/ß-catenin pathway inhibitor calcimycin in colon cancer cells. Mol Biol Cell. 2011;22:3344-54.
31. Lee SJ, Choi SY, Kim WJ, et al. Combined aberrant expression of E-cadherin and S100A4, b ut n ot ß -catenin is associated with disease-free survival and overall survival in colorectal cancer patients. Diagn Pathol. 2013;8:99.
32. Boye K, Nesland JM, Sandstad B, et al. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer. Br J Cancer. 2012;107:667-74.
33. Jiang B, Mason J, Jewett A, et al Cell budding from normal appearing epithelia: a predictor of colorectal cancer metastasis? In J Biol Sci. 2013;9:119-33.
34. Jiang B, Mason J, Jewett A, et al. Tube-like structures with co-expression of D2-40 and CD34: newly formed vasculatures? Int J Biol Sci. 2012;8:1206-16.